Skip to main content
SpringerLink
Log in

Prospects for an Effective Vaccination Against Herpesviruses

  • Conference paper
Herpetische Augenerkrankungen

  • 67 Accesses

Summary

Herpes virus vaccines should prevent the symptoms of primary infections and should abolish or at least reduce recurrent herpetic lesions. The present state of the development of vaccines against herpes simplex virus and other herpes group viruses is briefly reviewed and the prospects for an effective control of herpesviruses by vaccination are discussed. Recent data indicating reinfection with different virus strains in previously infected individuals resulting in herpes simplex virus latency stress the problems in controlling herpetic diseases.

Zusammenfassung

Herpesvirus-Vakzinen sollten in der Lage sein, eine Primärinfektion zu verhüten und rezidivierende Herpeserkrankungen zu unterbinden oder zumindest im Verlauf zu mildern. Auf den gegenwärtigen Entwicklungsstand bei den Vakzinen gegen Herpes simplex-Virus und andere Viren der Herpesgruppe wird kurz eingegangen und die Aussichten für eine wirkungsvolle Kontrolle der Herpesviren mittels Schutzimpfung werden diskutiert Neuere Befunde zeigen, daß auch vorinfizierte Individuen noch mit verschiedenen anderen Virusstämmen re-infiziert werden können, die alle wieder latent verbleiben. Dies zeigt die Schwierigkeiten bei der Kontrolle herpetischer Erkrankungen auf.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Douglas RG, Couch RB (1970) A prospective study of chronic herpes simplex virus infection and recurrent herpes labialis in humans. J Immunol 104: 289–295

    PubMed  CAS  Google Scholar 

  2. Wilton JMA, Ivanyi L, Lehner T (1972) Cell-mediated immunity in herpesvirus hominis infection. Br Med J 1: 723–726

    Article  PubMed  CAS  Google Scholar 

  3. Russel AS, Percy SJ, Kovithavongs T (1975) T-cell - mediated immunity to herpes simplex in humans: lymphocyte cytotoxicity measured by 51Cr release from infected cells. Infect Immunol 11: 355–359

    Google Scholar 

  4. Steele RW, Vincent MM, Hensen SA, Fucillo DA, Chapa IA, Canales J (1975) Cellular immune responses to herpes simplex virus type 1 in recurrent herpes labialis: in vitro histogenesis and cytotoxicity to infected cell lines. J Infect Dis 131: 528–534

    Article  PubMed  CAS  Google Scholar 

  5. Bastian FO, Rabson AS, Yee CL, Tralka TS (1972) Herpes-virus hominis: isolation from human trigeminal ganglion. Science 178: 306–307

    Article  PubMed  CAS  Google Scholar 

  6. Blank H, Haines GH (1976) Viral diseases of the skin, 1975; a 25-year perspective. J Invest Dermatol 67: 169–176

    Article  PubMed  CAS  Google Scholar 

  7. Baringer JR (1974) Recovery of herpes simplex virus from human sacral ganglions. N Engl J Med 291: 828–830

    Article  PubMed  CAS  Google Scholar 

  8. Jones KW, Fenoglio CM, Shevchuk-Chaban M, Maitland WJ, McDougall JK (1978) Detection of herpes simplex virus type II mRNA in human cervical biopsies by insitu cytological hybridization; in: Oncogenesis and Herpes-viruses III (G. de-Thé, W. Henle and F. Rapp eds.) part II, international agency for research on cancer, Lyon, pp 917–926

    Google Scholar 

  9. Reedman BM, Klein G (1973) Cellular localization of an Epstein-Barr virus-associated complement-fixing antigen in producer and non-producer lymphoblastoid cell lines. Int J Cancer 11: 499–520

    Article  PubMed  CAS  Google Scholar 

  10. zur Hausen H, O’Neill F, Freese UK, Hecker E (1978) Persisting oncogenic herpesvirus induced by the tumor promoter TP A. Nature 272: 373–375

    Article  PubMed  Google Scholar 

  11. Bister K, Yamamoto N, zur Hausen H (1979) Differential inducibility of Epstein-Barr virus in cloned Raji cells. Int J Cancer 23: 818–825

    Article  PubMed  CAS  Google Scholar 

  12. Yamamoto N, Bister K, zur Hausen H (1979) Inhibition of Epstein-Barr virus induction by retonoic acid. Nature 278: 553–554

    Article  PubMed  CAS  Google Scholar 

  13. Tovey MG, Lenoir G, Begon-Lours J (1978) Activation of latent Epstein-Barr virus by anti-body to human IgM. Nature 276: 270–272

    Article  PubMed  CAS  Google Scholar 

  14. Müller AS, Hermann EC, Winkelmann RK (1972) Herpes simplex infections in haematologic malignancies. Am J Med 52: 102–114

    Article  PubMed  Google Scholar 

  15. zur Hausen H, Bornkamm GW, Schmidt R, Hecker E (1979) Tumor initiators and promoters in the induction of Epstein-Barr virus. Proc Nati Acad Sci USA 76: 2

    Article  Google Scholar 

  16. Buchman TG, Roizman B, Nahmias AF (1979) Demonstration of exogenous genital reinfection with herpes simplex virus type 2 by restriction endonuclease fingerprinting of viral DNA. J Infect Dis 140: 295–304

    Article  PubMed  CAS  Google Scholar 

  17. Hilleman MR (1976) Herpes simplex vaccines. Cancer Res 36: 857–858

    PubMed  CAS  Google Scholar 

  18. Wise TG, Pavan PR, Ennis FA (1977) Herpes simplex virus vaccines. J Infect Dis 136: 706–711

    Article  PubMed  CAS  Google Scholar 

  19. Urbain A, Schaeffer W (1929) Contribution á Pétude expérimentale d’un virus herpétique (Souche Marocaine). Ann Inst Pasteur 43: 369–385

    Google Scholar 

  20. Holden M (1932) The nature and property of the virus of herpes. J Infect Dis 50: 218–236

    Article  CAS  Google Scholar 

  21. Martin N, Caneja D (1933) Tratamiento biologico herpes ocular. Arch Ottal 33: 367–369

    Google Scholar 

  22. Brain RT (1936) Biological therapy in virus diseases. Br J Derm 48: 21–26

    Article  Google Scholar 

  23. Frank SB (1938) Formolized herpesvirus therapy and the neutralizing substance in herpes simplex. J Invest Dermatol 1: 267–282

    Article  CAS  Google Scholar 

  24. McKendall RR, Baringer R (1980) Evidence for B-cell effectiveness on peripheral challenge by HSV-1 in mice. Abstract, International Conference on Human Herpesviruses Atlanta, March 17–21, 1980

    Google Scholar 

  25. zur Hausen H (1975) Oncogenic herpesviruses. Biochim Biophys Acta 417: 25–53

    PubMed  Google Scholar 

  26. Duff R, Rapp F (1971) Oncogenic transformation of hamster cells after exposure to herpes simplex type 2. Nature 233: 48–50

    Article  CAS  Google Scholar 

  27. Hampar B, Lenoir G, Nonoyama M, Derge JG, Chang S-Y (1976) Cell cycle dependence for activation of Epstein-Barr virus by inhibitors of protein synthesis or medium deficient in arginine. Virology 69: 660–668

    Article  PubMed  CAS  Google Scholar 

  28. Boyd AL, Derge JG, Hampar B (1978) Activation of endogenous type C virus in Balb/c mouse cells by herpesvirus DNA. Proc Natl Acad Sci USA 75: 4558–562

    Article  PubMed  CAS  Google Scholar 

  29. Rapp F, Hsu TC (1965) Viruses and mammalian chromosomes. IV. Replication of herpes simplex virus in diploid Chinese hamster cells. Virology 25: 401–411

    Google Scholar 

  30. Waubke R, zur Hausen H, Henle W (1968) Chromosomal and autoradiographic studies of cells infected with herpes simplex virus. J Virol 2: 1047–1054

    PubMed  CAS  Google Scholar 

  31. Hiatt HH, Watson JD, Winsten JA (eds) (1977) Origins of Human Cancer. Cold Spring Harbor Laboratory

    Google Scholar 

  32. Discussion on Contribution pp. 59–65

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Freiburg, Germany

    H. zur Hausen

Authors
  1. H. zur Hausen
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Augenklinik der Universität Freiburg, Killianstr. 5, D-7800, Freiburg i.Br., Germany

    Rainer Sundmacher

Rights and permissions

Reprints and permissions

Copyright information

© 1981 J.F. Bergmann Verlag, München

About this paper

Cite this paper

zur Hausen, H. (1981). Prospects for an Effective Vaccination Against Herpesviruses. In: Sundmacher, R. (eds) Herpetische Augenerkrankungen. Internationales Symposion der Deutschen Ophthalmologischen Gesellschaft vom 12. bis 14. April 1980 in Freiburg. J.F. Bergmann-Verlag. https://doi.org/10.1007/978-3-642-80499-1_10

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-80499-1_10

  • Publisher Name: J.F. Bergmann-Verlag

  • Print ISBN: 978-3-8070-0324-5

  • Online ISBN: 978-3-642-80499-1

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation